Hydroxy-triglycerides for membrane lipid regulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current oils, despite their health benefits, have limited pharmacological activity for treating diseases due to their role as cell fuel, primarily offering preventive effects rather than therapeutic treatment, and their effects are circumscribed to maintaining health rather than reversing pathological conditions.

Innovation Solution

Development of hydroxy-triglycerides with specific aliphatic chains that regulate membrane lipid composition and structure, allowing for the prevention and treatment of diseases by modifying cell functions and plasma lipid profiles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If natural triglycerides (oils) are used as nutrients, then health prevention benefits are achieved through regulation of circulating lipids and membrane composition, but pharmacological activity for treating diseases is limited due to their role as cell fuel

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoiddisease treatment spectrum
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent introduces a hydroxyl group at the 2-position of the triglyceride molecule, changing the chemical structure from natural triglycerides to hydroxy-triglycerides. This structural parameter change prevents metabolism by lipoprotein lipase, allowing the compound to accumulate and exert therapeutic effects on membrane lipids without being consumed as fuel, thereby achieving both reliability and versatility in disease treatment

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The hydroxy-triglyceride acts as an intermediary substance that regulates membrane lipid composition and structure. It serves as a mediator between the administered compound and the target membrane lipids, indirectly treating diseases by modifying membrane properties rather than directly attacking pathogens or disease mechanisms

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If oils rich in unsaturated fatty acids are consumed, then positive health effects are achieved through prevention of cardiovascular diseases, diabetes, and inflammation, but therapeutic effect for treating established diseases is not relevant

Engineering Contradiction:
Improvedisease prevention capabilityVSAvoidtherapeutic treatment effectiveness
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

By modifying the triglyceride structure to include a hydroxyl group at the 2-position, the patent creates a compound that resists metabolic breakdown. This parameter change transforms the substance from a transient fuel source to a stable therapeutic agent that can accumulate and exert sustained therapeutic effects on membrane lipids, achieving reliability in treating established diseases while maintaining prevention capabilities

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The hydroxy-triglyceride exerts a stronger and more persistent action on membrane lipid regulation compared to natural triglycerides. The excessive accumulation of the compound in membranes leads to significant structural modifications that can reverse pathological conditions, going beyond the mild preventive effects of natural oils

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentEP3209637B12-hydroxy-triacylglycerol compounds for use in treating disease
Publication Date: 2019.05.08 UNIV DE LAS ISLAS BALEARES
  • EP3209637B1 patent drawingFigure 1A~1C
  • EP3209637B1 patent drawingFigure 2A~2B
  • EP3209637B1 patent drawingFigure 2C~2D

AI summary

The present invention relates to hydroxy-triglycerides, their synthesis, a pharmaceutical and/or nutraceutical composition which comprises at least one of said hydroxy- triglycerides, and a method which comprises the administration to a patient of a therapeutically effective quantity of at least one of said hydroxy-triglycerides or at least one of said pharmaceutical and/or nutraceutical compositions, for the prevention and/or treatment of at least one disease selected from cancer, metabolic/cardio vascular diseases, and/or neurological/inflammatory diseases.